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The existence of a sex gap in human health and longevity has been widely documented. Autosomal DNA 
methylation differences between males and females have been reported, but so far, few studies have 
investigated if DNA methylation is differently affected by aging in males and females. We performed a meta-
analysis of 4 large whole blood datasets, comparing 4 aspects of epigenetic age-dependent remodeling  
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between the two sexes: differential methylation, variability, epimutations and entropy. We reported that a 
large fraction (43%) of sex-associated probes undergoes age-associated DNA methylation changes, and that a 
limited number of probes show age-by-sex interaction. We experimentally validated 2 regions mapping in FIGN 
and PRR4 genes and showed sex-specific deviations of their methylation patterns in models of decelerated 
(centenarians) and accelerated (Down syndrome) aging. While we did not find sex differences in the age-
associated increase in epimutations and entropy, we showed that the number of probes having an age-related 
increase in methylation variability is 15 times higher in males compared to females. Our results can offer new 
epigenetic tools to study the interaction between aging and sex and can pave the way to the identification of 




A profound and multifaceted remodeling of DNA 
methylation patterns occurs during human aging [1–3]. 
DNA methylation profiles tend to diverge among 
individuals during life course [4–6], shaped by an 
intricate combination of environmental exposures, 
random events and genetically-driven mechanisms. 
Several epigenome-wide association studies (EWAS) 
have shown that a subset of the about 28 million CpG 
sites of the genome undergoes age-associated 
normative changes, i.e. reproducible hypermethylation 
or hypomethylation events that normally occur in all 
individuals during physiological, healthy aging 
(normative aging) [7, 8]. Despite some controversial 
results [9, 10], at least a fraction of normative 
epigenetic changes is tissue-specific, indicating that 
the cellular microenvironment affects the activity of 
the molecular writers of DNA methylation patterns 
during aging. In the last 10 years an increasing number 
of studies identified age-associated DNA methylation 
changes at the level of single CpG sites, paving the 
way for the development of models, termed 
“epigenetic clocks”, that predict age starting from the 
epigenetic profile [11]. Epigenetic clocks are an 
appealing resource for chronological age estimation in 
forensic applications, but they have risen to the 
limelight particularly because multiple reports have 
shown that they are sensitive to health status and are 
thus informative of the biological age of an individual. 
Although a conclusive association between epigenetic 
clock predictions and risk of age-related diseases is 
still missing [12], several independent studies showed 
that epigenetic age acceleration (i.e., predicted 
epigenetic age higher than effective chronological age) 
is associated with age-related diseases like cancer, 
cardiovascular disease and neurodegenerative 
conditions and to all-cause mortality [13]. On the  
other side, epigenetic age deceleration was reported to 
be associated with successful aging and longevity  
[14, 15]. 
 
Surprisingly, the research on the DNA methylation 
changes occurring during aging has largely neglected 
one of the hot topics in aging research, i.e. the sex 
differences in lifespan and health span.  
 
According to Global Health Observatory (GHO) data 
[16], global life expectancy at birth in 2016 was 74.2 
years for females and 69.8 years for males and, 
although with a different extent, this sex gap in 
longevity is worldwide [17]. At the same time, 
epidemiological data indicate that women live longer 
than men but experience a worse quality of life in 
advanced age [18]. Sex disparity exists for several 
diseases: cardiovascular disease, cancer and Parkinson’s 
disease have higher mortality rates in males than in 
females at a given age, while females are at higher risk 
of Alzheimer’s disease and show an increased 
prevalence of disabling conditions like bone and joint 
problems and autoimmune diseases. The reasons for 
these differences are still unclear, but they likely result 
from a strict interplay between nature (for example, 
differences in hormone levels, asymmetries in genetic 
inheritance, sexual dimorphism) and nurture (for 
example, different vulnerability to environmental 
hazards, sexual selection) [19]. Notably, sex-specific 
longevity loci have been recently identified [20], further 
pointing out the contribution of sex on aging 
trajectories.   
 
Independent studies reported DNA methylation 
differences between males and females in various 
tissues [21–23], involving CpG sites widespread across 
the autosomal chromosomes. These differences mirror 
the diversity in transcriptomic and proteomic profiles 
between the two sexes that have been recently reported 
[24, 25]. However, few studies have investigated 
whether DNA methylation differences exist between 
males and females during aging and whether they 
contribute to the sex gap in aging and longevity. 
According to Horvath’s clock, males have an 
acceleration in epigenetic age compared to females  
[26–28]. Masser et al. analyzed genome-wide DNA 
methylation in mouse hippocampus and human frontal 
cortex and reported CpG sites that show different DNA 
methylation levels between males and females lifelong 
(referred as sex differences) and CpG sites that are 
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differently affected by aging in males and females 
(referred as sex divergence) [29]. The vast majority of 
EWAS studies on aging have been performed in whole 
blood, but sex has usually been exiled as a confounding 
factor and used to adjust DNA methylation data. 
 
In the present work we specifically investigated sex 
differences in whole blood DNA methylation changes 
during aging. We provide the results of a 
comprehensive study of 4 large whole blood datasets 
considering different aspects of age-associated 
epigenetic remodeling that can, either individually or in 
combination, contribute to the sex-specificity of human 
aging and longevity. In particular we focused on: 1) 
age-related changes in DNA methylation levels [8, 30]; 
2) age-related increase in DNA methylation variability, 
as described by Slieker et al. [6]; 3) age-related increase 
in epimutations, i.e. rare or stochastic changes in DNA 
methylation levels that are not shared among subjects, 
as defined by Gentilini et al. [5] 4) age-related increase 
in entropy in DNA methylation profiles, as previously 
described by Hannum et al. [31]. Furthermore, we 
investigated a subset of the loci emerged from these 
analyses in human models of successful and 
unsuccessful aging. Our results are compared with the 
only study that, to the best of our knowledge, recently 
investigated age-by-sex DNA methylation differences 
in whole blood of a single population, i.e. a large 




Identification of sex- and age-associated 
differentially methylated positions  
 
We performed a meta-analysis of 4 large datasets on 
whole blood (Materials and Methods) to identify CpG 
sites with differential methylation between males and 
females (sex-associated differentially methylated 
positions, sDMPs). We identified 38100 sDMPs 
(Bonferroni corrected p-values resulting from meta-
analysis <0.01), 53% of which were hypermethylated in 
females compared to males. We used the same datasets 
to identify age-associated differentially methylated 
positions (aDMPs) and we selected a list of 87581 
probes (Bonferroni corrected p-values resulting from 
meta-analysis <0.01), 52% of which underwent 
hypermethylation with aging. We then asked how many 
sDMPs underwent DNA methylation changes with age, 
i.e. were also aDMPs. The intersection between sDMPs 
and aDMPs lists returned 16526 probes, that we defined 
sex- and age-associated differentially methylated 
positions (saDMPs); we defined the remaining probes 
(21574) sex- but not age-associated differentially 
methylated positions (snaDMPs). Figure 1A reports a 
graphical representation of the procedure used to 
identify saDMPs and snaDMPs. The proportion of sex-
associated probes showing age-associated changes 
(16526 out 38100) was higher then expected, 
considering the proportion of age-associated probes in 
the genome (87581 out 327905; Fisher’s exact test p-
value < 2*10-16, odds ratio 2.35). We found that most 
of the saDMPs undergoing hypomethylation with age 
were more methylated in males compared to females, 
while most of the age-hypermethylated saDMPs were 
more methylated in females compared to males (Figure 
1B). Four examples of saDMPs are depicted in Figure 
1C. The lists of saDMPs and snaDMPs are reported in 
Supplementary File 1.  
 
When compared to previously published studies, we 
found that a total of 1121 saDMPs and 2163 snaDMPs 
were reported to have sex-dependent methylation 
(independently from age) in previous reports [21–23], 
also when newborns were considered [23] 
(Supplementary File 1). 
 
We then investigated the possible functional role of 
saDMPs and snaDMPs. First of all, we explored 
whether the selected probes were enriched in specific 
genomic regions (Supplementary Figure 1), and we 
found that both saDMPs and snaDMPs were 
significantly enriched in Shore regions. The list of 
saDMPs, but not of snaDMPs, was significantly 
depleted in imprinted regions (p-value = 0.04, odds 
ratio: 0.64), as defined by Court et al. [33]. We also 
checked for the presence of sex hormone-related genes, 
as suggested by [22], in the lists of saDMPs and 
snaDMPs. saDMPs and snaDMPs mapped in 6610 and 
8367 genes respectively. 2899 genes were shared 
between the two lists, indicating that the same gene can 
include multiple CpG sites with DNA methylation 
differences between males and females, only a subset of 
which shows also age-associated changes. The list of 
saDMPs included a higher proportion of hormone-
related genes (28/6610 genes for saDMPs; 29/8367 for 
snaDMPs), but the enrichment was not statistically 
significant (p-value: 0.08; odds ratio: 1.6). Then, we 
analyzed the two lists for their enrichment in gene 
ontologies according to the GO database. While the list 
of snaDMPs was not enriched in any biological process 
(FDR corrected p-value<0.01), saDMPs were enriched 
in multiple ontologies related to neuronal and 
developmental functions and to cell-cell interactions 
(Supplementary File 2). 
 
Finally, we evaluated age-by-sex interactions in the 4 
datasets. Meta-analysis resulted in 8 CpG probes whose 
methylation showed different aging trajectories 
according to sex (Supplementary File 3). Two of these 
CpG sites were previously identified as having age-by-
sex interaction in whole blood [32], and the most 
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significant CpG site (cg18834375) mapped within the 
FIGN gene, that was the top ranker also in the list of 
saDMPs and included multiple CpG sites showing sex- 
and age-dependent methylation (cg01620164, 
cg19156483, cg10864319, cg18834375, cg15259986 
and cg03878133).  
 
Validation of saDMPs 
 
A subset of the above-identified saDMPs was 
experimentally validated using the EpiTYPER assay, a 
high throughput approach for target DNA methylation 
analysis. Target regions were chosen within FIGN and 
PRR4. We analyzed whole blood from 198 males from 
15 to 98 years old and 221 females from 23 to 98 years 
old.  
 
The FIGN target region included 13 CpG sites; of these, 
7 were measurable by the assay, grouped in 5 CpG 
units. CpG unit 3.4.5 included the microarray probe 
cg01620164. We found that this group of CpG sites 
showed a sex-specific DNA hypomethylation trajectory 
comparable to what observed in the microarray 
(Supplementary Figure 2); also, the adjacent CpG sites 
showed a similar profile (Supplementary Figure 2), in 
particular CpG unit 9 (Figure 2A). This result indicates 
that the CpG sites located in this genomic region of at 
least 250bp are concordantly regulated in whole blood 
during aging according to sex. 
 
The PRR4 target region included 5 CpG sites, all 
assessable by EpiTYPER and all corresponding to an 
Infinium450k probe; CpG units 3 and 4, corresponding 
to the Infinium450k probes cg23256579 and 
cg27615582, had the same mass and returned the same 
methylation value in the EpiTYPER assay. While CpG 
units 1 and 2 did not show age-dependent changes nor 
sex specificity (Supplementary Figure 3), CpG units 3 
and 4 showed sex-dependent trajectories with aging 
(Figure 2B). Although less evident, also CpG 5 showed 
sex-related differences in age-associated methylation 




Figure 1. Identification of sex- and age-associated differentially methylated positions (saDMPs). (A) The procedure used to 
identify saDMPs and snaDMPs. (B) Scheme of the number of sDMPs, aDMPs and saDMPs, divided according to the direction of 
methylation changes respect to sex (hyper- or hypo-methylated in males compared to females) and age (hyper- or hypo-methylated 
with increasing age). (C) Scatter plots of a selection of saDMPs: cg01620164 is hypomethylated in males and undergoes age-associated 
hypomethylation; cg03890691 is hypomethylated in males and undergoes age-associated hypermethylation; cg07128102 is 
hypermethylated in males and undergoes age-associated hypomethylation; cg04628369 is hypermethylated in males and undergoes 
age-associated hypermethylation. 
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We used the EpiTYPER assay to investigate the two 
validated loci in samples from additional cohorts 
available in our laboratory: persons affected by Down 
syndrome, that we previously demonstrated to have an 
acceleration in epigenetic age [34, 35]; and centenarians 
and their offspring, as a model of successful aging 
experiencing a deceleration in epigenetic age [14]. 
Interestingly, we found sex-dependent patterns of FIGN 
and PRR4 methylation also in these models. Compared 
to aged controls (>80 years old), centenarian males 
displayed highly variable DNA methylation profiles  
for FIGN amplicon, with about half of the subjects 
showing a female-like DNA methylation level (Figure 
2A, 2C, Supplementary Figure 4); the differences in 
variance between control and centenarians' males (but 
not females) reached statistical significance for CpG 
unit 9 (F-test p-value: 0.02). No specific trends were 
found for PRR4 amplicon in the centenarians' cohort 
(Supplementary Figure 5). Centenarians’ offspring 
showed DNA methylation patterns comparable to  
age-matched controls for both the amplicons 
(Supplementary Figures 4 and 5). Persons affected by 
Down syndrome showed DNA methylation profiles 
similar to age-matched controls in FIGN locus 
(Supplementary Figure 4). On the contrary, females 
affected by Down syndrome showed lower values of 
CpG unit 3 in PRR4 amplicon compared to sex- and 
age-matched healthy controls (ANOVA p-value 
correcting for age: 6.2*10-5), while no significant 
differences were found between males affected by 
Down syndrome compared to sex- and age-matched 
controls (Figure 2B and 2D, Supplementary Figure 5). 
The results of the statistical analyses performed on the 
centenarians', centenarians' offspring and Down 
syndrome cohorts are summarized in Supplementary 
File 4. 
 
Identification of sex-specific age-associated variably 
methylated positions (saVMPs) 
 
An increase in inter-individual DNA methylation 




Figure 2. Validation of FIGN and PRR4 loci by EpiTYPER. (A) Methylation of CpG unit 9 in FIGN amplicon vs age. (B) Methylation of CpG 
unit 3 in PRR4 amplicon vs age. (A and B) For each CpG unit, DNA methylation in controls (general population), centenarians, centenarian's 
offspring and persons with Down syndrome is reported vs the age of the subjects. Males are in blue, females are in red. Linear regression 
between DNA methylation and age was calculated separately for males and females in control subjects and was reported in each plot. (C) 
Boxplots of DNA methylation of CpG unit 9 in FIGN amplicon in aged controls and centenarians. (D) Boxplots of DNA methylation of CpG unit 
3 in PRR4 amplicon in healthy controls and persons with Down syndrome. 
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sex-specific effects have not been investigated so far. 
To have a general view of the sex-dependent trends in 
age-related increase in DNA methylation variability, we 
plotted the density distributions of standard deviation 
values, calculated in the GSE87571 dataset (the one 
with the most homogeneous distribution of ages) in 3 
age-ranges (14-39 years; 40-59 years; 60-94 years) 
considering the whole cohort (Figure 3A) or separating 
males and females (Figure 3B). A clear increase in 
standard deviation across the 3 age ranges was evident 
when considering the entire cohort. No clear differences 
between males and females were evident in the first 2 
age ranges, while we found a trend towards higher 
variability in males in the oldest group. 
 
To identify probes having sex-specific differences in 
age-dependent variability (sex-specific age-associated 
variably methylated positions, saVMPs), we applied the 
approach described in Materials and Methods and 
reported in Figure 4A. We identified 809 and 12178 
saVMPs specific for females and males respectively 
(Supplementary File 5). All the female-specific saVMPs 
displayed increased variability with age, and similarly 
only for 5 out of 12178 male-specific saVMPs 
variability decreased with age. No probes with opposite 
trends in the two sexes were identified. Some examples 
of female- and male-specific saVMPs are reported in 
Figures 4B–4E. 
 
While female-specific saVMPs were enriched in 
Islands, male-specific saVMPs were enriched in Shore 
regions (Supplementary Figure 6). We also found that 
male-specific saVMPs were enriched in imprinted 
regions and mapped in 20 hormone-related genes, 
although this enrichment was not significant (p-value: 
0.09; odds ratio: 1.66). Both female- and male-specific 
saVMPs were enriched in several gene ontologies 
related to neuronal and developmental processes, with 
some ontologies shared between the two lists 
(Supplementary File 6). 
 
Epimutations and entropy analysis 
 
Epimutations were calculated in each dataset as 
previously described [5]. As shown in Figure 5A, we 
confirmed an increase in the number of epimutations with 
age both in males and females (p-value <0.01 in all the 
datasets), but no sex-specific trends were found according 
to ANCOVA model (Supplementary Table 1). 
 
The dependence of Shannon entropy on age for the 4 
datasets is shown in Figure 5B. Entropy showed a 
significant increase with age (p-value <0.01) in the 
GSE87571, EPIC and GSE55763 datasets 
(Supplementary Table 1), while it differed between the 
two sexes only in the EPIC dataset. EPIC dataset. These 
results suggest that there were no robust differences 





Males and females experience different aging 
trajectories for several phenotypic traits [36, 37]. Sex-
specificity is established and maintained by differential 
genomic regulation, as evidenced by the profound 
transcriptomic, epigenomic and proteomic differences 
between males and females. However, how these 
differences in genome regulation evolve during life 
course has been poorly investigated, thus leaving a gap 
in our understanding of sexual dimorphism in aging and 




Figure 3. Probability density function (PDF) of standard deviation values calculated in the GSE87571 dataset for 3 age classes, considering 
males and females together (A) or separated (B). 
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In the present study we aimed at filling this gap by 
exploiting 4 large EWAS on human whole blood, 
including men and women of different ages and 
populations, in which we analyzed the sex specificity of 
age-associated normative changes, variability, 
epimutations and entropy.  
 
The main findings we will discuss are the following: i) a 
large fraction of probes with sex-specific DNA 
methylation undergoes also hyper- or hypo-methylation 
during aging, and a small number of probes show 
significant age-by-sex interaction; ii) the methylation of 
2 selected saDMPs, mapping in FIGN and PRR4 genes, 
is differently modulated in centenarians and Down 
syndrome persons, assumed as human models of 
successful and unsuccessful aging [14, 34, 35]; iii) 
males display a higher number of saVMPs respect to 
females, the vast majority of which show an age-
associated increase in methylation variability; iv) males 
and females do not differ for the age-associated increase 
in epimutations and entropy. 
 
saDMPs in healthy subjects of different ages and 
populations. 
 
We reported that 43% of probes showing sex-associated 
DNA methylation differences in whole blood display 
also age-associated changes (saDMPs). This result 
suggests that CpG sites with blood DNA methylation 
differences between males and females are particularly 
prone to undergo epigenetic changes during aging. 
Interestingly we found that while saDMPs were 
enriched in gene ontologies related to neuronal and 
developmental functions, snaDMPs were not enriched 
in any particular biological process. When considering 
autosomal differences in DNA methylation between 
men and women (correcting for age), Singmann et al. 




Figure 4. Identification of sex-specific age-associated variably methylated positions (saVMPs) (A) The approach used to identify saVMPs.  
(B–E) Some examples of saVMPs showing age-associated increase in variability in males (B, C), age-associated decrease in variability in males 
(D) or age-associated increase in variability in females (E). x axis corresponds to age of subjects, y axis to methylation levels. 
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imprinted genes, but they did not find an enrichment in 
sex hormone-related genes [22]. Our list of saDMPs 
was enriched in CpG island shores but depleted in 
imprinted genes. We did not find any significant 
enrichment in sex-hormone related genes, although 
saDMPs included a higher proportion of this class of 
genes compared to snaDMPs. Finally, we searched  
for those probes displaying different DNA methylation 
trajectories in males and females during aging. We 
identified 8 probes having age-by-sex interaction, 2  
of which were recently reported by McCartney et al.  
in an independent dataset [32]. In particular we  
found that FIGN gene included both probes from the 
saDMPs list and probes displaying an age-by-sex 
interaction. 
 
It is difficult to speculate on the mechanisms that 
regulate saDMPs and on the functional consequences of 
this differential methylation in blood. By way of 
example, we considered the genes in which the 5 top 
ranker saDMPs map and we evaluated their tissue-
specific gene expression profiles in the GTEx portal 
(https://www.gtexportal.org/home/). FIGN gene 
encodes for Fidgetin protein, an ATP-dependent 
microtubule severing enzyme that catalyses internal 
breaks in microtubules and is involved in different 
cellular processes, including cell division and 
neurogenesis [38]. The gene is poorly expressed in 
whole blood, while it is expressed at higher levels in 
arteries and female reproductive organs. DOC2A 
(Double C2 Domain Alpha) is mainly expressed in 
testis and brain, where it acts as a Ca2+ sensor and 
regulates asynchronous neurotransmitter release [39]. 
PEX10 (Peroxisomal Biogenesis Factor 10) encodes for 
a protein localized to the peroxisomal membrane and 
involved in the import of peroxisomal matrix proteins. 
The gene is highly expressed in testis, and a meta-
analysis suggests that PEX10 polymorphisms are 
associated with male infertility, especially with non-
obstructive azoospermia susceptibility [40]. PRR4 gene 
encodes for Proline-rich protein 4, a poorly 
characterized protein with very low expression in most 
human tissues, except for tear fluid [41]. It is worth of 
note that several of these genes are expressed in 
reproductive organs, and we cannot exclude that the 
observed epigenetic changes in whole blood are a proxy 
of what happens in these tissues. None of these genes 
was differentially expressed in PBMCs from 
nonagenarians with respect to young controls 
(GSE65219), or when males and females from the same 
cohort were compared [42]. Notwithstanding, using the 
“Ominer” tool in the Signaling Pathways Project [43] 
website (https://www.signalingpathways.org/ominer/ 
query.jsf), we found that all the 4 genes are regulated in 
cellular models (mainly epithelial cells) treated with 
bioactive small molecules that bind to estrogen and 
androgen receptors (Supplementary File 7). Future 
studies would clarify whether sex- and age-dependent 
methylation of these genes occurs also in tissues 
different from blood, whether this affects their 
expression and whether hormones directly regulate 
them across the lifespan. 
 
saDMPs in centenarians and Down syndrome 
persons. 
 
Another question is whether the saDMPs that we 
identified are modulated according to biological age. To 
this aim, we exploited two cohorts available in our lab, 
in which we measured whole blood DNA methylation 
by the targeted EpiTYPER assay: subjects affected by 
Down syndrome, as a model of premature/accelerated 
aging [34, 35], and centenarians, as a model of 
successful/decelerated aging [14]. The results are 
intriguing, as both models showed a peculiar sex 




Figure 5. (A) Number of epimutations (log scale) in dependence on age in females (red) and males (blue). (B) Shannon entropy for 4 
considered datasets: GSE40279, GSE87571, EPIC, GSE55763. 
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patterns. In particular, a subset of centenarian males 
showed a “feminization” of FIGN methylation values, 
while females with Down syndrome showed a 
“masculinization” of PRR4 methylation values. No 
differences were found in the centenarians’ offspring 
group, despite we and others previously showed an 
epigenetic age deceleration effect in these subjects 
[14]. Interestingly, the “feminization” of centenarians 
methylation profiles at FIGN locus is reminiscent of 
the gene expression shift towards female patterns 
observed after caloric restriction [44, 45]. Further 
studies should deepen these results and identify other 
changes in saDMPs that are associated with age-
related diseases or longevity. 
 
saVMPs in healthy subjects of different ages and 
populations.  
 
An increase in epigenetic variability has been reported 
during aging [6], in line with what observed for other 
molecular layers [46–48]. In the GSE87571 cohort we 
showed a global increase in DNA methylation variance 
during aging, and we further reported a trend towards 
higher variance in males compared to females at older 
ages. This result mimics what was observed for gene 
expression in the hippocampus of male and female 
mice at different ages [49], thus suggesting that the 
loss of epigenetic and transcriptional control that 
occurs during aging is more marked in males than in 
females. Accordingly, a more specific search for 
saVMPs showed that in males the number of probes 
displaying age-related changes in methylation 
variability is 15 times higher than in females and that 
the vast majority of these probes undergo an increase 
in age-related variability, as previously reported [6]. 
Interestingly, this list was significantly enriched in 
imprinted regions. An increase in variability at these 
loci can be related to the phenomenon of loss of 
imprinting, which has been largely reported in cancer 
and demonstrated to occur during aging [50–52].  
 
Epimutations and entropy   
 
While variable probes are defined at the level of 
population, epimutations are rare methylation changes 
that are specific for one or few individuals within a 
certain population. As such, variable probes and 
epimutations represent distinct aspects of epigenetic 
instability, that can be differently triggered during 
aging and that can differently affect aging trajectories. 
Accumulation of epimutations has been reported in 
cancer [53], and we and others demonstrated that the 
number of epimutations increases with age [5, 54]. 
Recently, Wang and colleagues showed that the 
number of epimutations in whole blood tends to be 
higher in females compared to males [54]. On the 
contrary, we failed to detect differences in the age-
related increase in epimutations between the two 
sexes. This discrepancy can be due to the different 
analytical approaches and/or to cohort-specific effects, 
as Wang et al investigated monozygotic and dizygotic 
twins longitudinally assessed. A recent paper assessed 
epimutations in 3 large cohorts and did not find 
significant differences between males and females 
[55]. Similarly, we did not find sex-related differences 
in age-related changes in Shannon entropy, another 
measure of epigenetic drift. 
 
Strengths and Limitations  
 
The main strengths of our work are: i) we compared 
the two sexes not only for age-associated hyper- or 
hypo-methylation changes, but also for other types of 
epigenetic remodeling (variability, epimutations, 
entropy) that, although less characterized, are likely to 
affect aging and be involved in the sex gap in 
longevity; ii) the analysis was performed in 4 distinct 
datasets including subjects recruited in different 
geographic area (United States, Sweden, Italy, United 
Kingdom) and belonging to different ethnic groups 
(European, Hispanic, Indian Asian). Population 
epigenetics is an emerging field. Some studies 
reported that epigenetic clock estimations can differ 
between ethnic groups, and that sex-dependent 
differences can be specific for some populations [26, 
27]. Our meta-analysis of datasets deriving from 
different populations and ethnic groups allowed us to 
disentangle the effects of sex from those of potentially 
confounding factors, like genetic background and 
socio-cultural aspects related to gender definition; iii) 
beside  healthy individuals representative of 
physiological aging, we evaluated also extreme 
phenotypes (persons with Down Syndrome, 
centenarians and their offspring) that provide a first 
descriptive insight on the possible contribution of sex-
specific methylation in the sex gap in aging and 
longevity. 
 
At the same time, our study has some limitations. The 
analyzed datasets differ in terms of size, age-range and 
data pre-processing procedures (in particular the 
GSE40279 dataset). It is therefore likely that our 
selection excluded additional CpG sites displaying a 
sex-specificity in their age-associated methylation 
trends, but not evident in all the datasets due to the 
above-mentioned differences between them. 
Furthermore, although some ethnic groups are 
included, many are missing, and the study of 
additional populations will be necessary to distinguish 
the effects of sex and gender in shaping age-related 
methylation changes. Finally, the first step of our 
pipeline (the identification of sDMPs) prevented us to 
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include in the analysis sex chromosomes, similarly to 
[22]. The analysis of sex- and age-dependent DNA 
methylation on sex chromosomes poses peculiar 
technical difficulties, due to the different number of X 
chromosomes in females and males and to the X-
chromosome inactivation (XCI) process in females. By 
normalizing raw methylation data in males and females 
separately (an approach not applicable to GSE40279 
and GSE55763 datasets included in our study, as raw 
data were not available in GEO), Li  
et al. recently reported a small number of CpG sites on 
X chromosome having sex-specific age-dependent 
changes in relation to XCI [56]. Similarly, Lund et al. 
evaluated the changes in Y chromosome methylation 
during aging [57]. Future studies based on alternative 
approaches, like allele-specific analysis of bisulfite-
sequencing data, will help in disentangling the 
dynamics of sex chromosomes methylation with aging, 
taking into account also possible age-dependent 
changes in XCI. 
 
CONCLUSIONS AND  
FUTURE PERSPECTIVES 
 
In conclusion, we provided a comprehensive 
description of sex-differences in DNA methylation 
changes with aging in whole blood. Our results suggest 
that a large fraction of CpG sites with sex-specific 
DNA methylation patterns are also modulated during 
aging, and that sex can affect some aspects of age-
related epigenetic remodeling, like an increase in 
variability in DNA methylation patterns. Future studies 
should investigate the tissue-specificity of these 
patterns and their relationship with gene expression 
differences between males and females, in particular 
for those probes that show age-by-sex interactions, to 
identify possible molecular triggers of sex gap in aging 
and longevity. Importantly, here we reported also a list 
of sex- but not age-associated probes, and we cannot 
exclude that also these sites can contribute to the 
dimorphism in aging phenotypes between males and 
females. 
 
Our results pave the way for the development of a new 
generation of sex-specific epigenetic clocks that, 
compared to the “unisex” clocks currently available, 
are likely to be more informative of the peculiar 
trajectories that males and females experience during 
aging. 
 




The Gene Expression Omnibus (GEO) Datasets 
repository [58] was interrogated using “GPL13534” 
(the accession code of the platform 
HumanMethylation450 BeadChip, Illumina) and 
“blood” as search terms, setting “tissue”, “age”, 
“gender” and “sex” as attributes and sorting the results 
by Number of Samples (High to Low). Only datasets 
including healthy subjects were considered. Based on 
these criteria, as to June 1st 2019 we selected the 3 
datasets including the highest number of samples: 
GSE40279 [31], GSE87571 [59] and GSE55763 [60]. 
Furthermore, we analyzed a fourth dataset not uploaded 
in GEO that is part of the EPIC Italy study [61]. The 
total number of subjects included in each dataset, as 
well as the number of males and females, are reported 
in Supplementary Table 2. Supplementary Figure 7 
reports, for each dataset, the number of males and 
females according to age. 
 
For the EPIC dataset, raw data were normalized using 
an in-house software written for the R environment and 
extensively described in [62]. For the datasets 
downloaded from GEO, raw data (.idat files) were 
available only for GSE87571. We extracted .idat files 
using minfi Bioconductor package and normalized 
them using the preprocessFunnorm function 
implemented in the same package [63]. For the 
remaining datasets, the analyses were performed on 
pre-processed beta value matrixes available in GEO: 
according to authors’ indications, the GSE55763 data 
were the result of a quantile normalization of intensity 
values, while GSE40279 beta values were not 
normalized but adjusted for internal controls by the 
Illumina's Genome Studio software. 
 
Probes mapping on sex chromosomes and probes with 
internal SNPs, with non-unique mapping to the 
bisulfite-converted genome and with off-target 
hybridization according to [64] were excluded from 
each dataset, leaving 414505 probes for GSE40279, 
414950 probes for GSE87571, 349534 probes for EPIC 
and 382458 probes for GSE55763. 327905 probes were 
common to the four datasets and were considered in the 
analyses described below. 
 
In each dataset, blood cell proportions were estimated 
from methylation data using Horvath’s calculator [65].  
 
Identification of age-associated probes having sex-
specific DNA methylation patterns 
 
To identify CpG sites showing DNA methylation 
differences between the two sexes and age-associated 
changes in DNA methylation (sex- and age-associated 
differentially methylated positions, saDMPs), we 
proceeded as follows (Figure 1A): 1) We meta-
analyzed the 4 datasets to identify probes with sex-
dependent DNA methylation patterns (sDMPs). As 
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previously described [22], in each dataset we calculated 
the p-value of Pearson’s correlation between sex and 
methylation beta-values, previously adjusted for age 
and blood cell proportions (CD8T cells, CD4T cells, 
NK cells, B cells and granulocytes, estimated as 
described above). METAL [66] was used to perform 
sample-size weighted meta-analysis on the 4 lists of 
Benjamini-Hochberg corrected p-values. 2) We meta-
analyzed the 4 datasets to identify probes with age-
dependent DNA methylation patterns (aDMPs). In each 
dataset, we calculated the p-value of Pearson’s 
correlation between age and methylation beta-values, 
previously adjusted for sex and blood cell proportions 
(CD8T cells, CD4T cells, NK cells, B cells and 
granulocytes, estimated as described above). As 
described above, METAL [66] was used to perform a 
sample-size weighted meta-analysis on the 4 lists of 
Benjamini-Hochberg p-values. 3) The meta-analyzed p-
values were corrected using Bonferroni procedure and 
a significance threshold of 0.01 was considered. 
Furthermore, only probes with a concordant trend in all 
the 4 datasets (for sDMPs: hypermethylated or 
hypomethylated in males respect to females in all the 
datasets; for aDMPs: hypermethylated of 
hypomethylated with age in all the datasets) were 
considered, returning a list of 38100 sDMPs and a list 
of 87581 aDMPs. 4) Finally, to identify saDMPs, we 
intersected the list of sDMPs and the list of aDMPs, 
resulting in a list of 16526 probes. 
 
Identification of probes having sex-specific trends in 
age-associated methylation variability 
 
To identify probes having sex-specific differences in 
age-dependent variability of methylation (sex-specific 
age-associated variably methylated positions, 
ssaVMPs) we proceeded as follows (Figure 3B): 1) We 
first regressed out the estimates of CD8T cells, CD4T 
cells, NK cells, B cells and granulocytes from beta 
values in each dataset; 2) To check for 
heteroscedasticity respect to age, we applied the 
Breusch-Pagan for males and females separately in 
each dataset [67, 68]. 3) Heteroscedasticity p-values 
were analyzed with sample-size weighted meta-
analysis using METAL [66] for males and females 
separately. The meta-analyzed p-values were corrected 
using Bonferroni procedure and a significance 
threshold of 0.01 was considered. 4) We defined 3 
possible scenarios of sex-specific differences in age-
dependent variability of methylation: a) Probes 
heteroscedastic in females and homoscedastic in males, 
that is probes with a meta-analyzed and Bonferroni-
corrected p-value less than 0.01 in females and higher 
than 0.05 in males. b) Probes homoscedastic in females 
and heteroscedastic in males, that is probes with a 
meta-analyzed and Bonferroni-corrected p-value less 
than 0.01 in males and higher than 0.05 in females. c) 
Probes heteroscedastic in both females and males, but 
with opposite directions of change in variability 
(variability increases in females and decreases in males 
or variability decreases in females and increases in 
males).  
 
Identification of epimutations and Shannon entropy 
analysis 
 
To identify epimutations (i.e., CpG probes for which 
one or few individuals show extremely different 
methylation levels compared to the rest of the cohort), 
for each probe we calculated the interquartile ranges of 
beta values; we then selected the probes having one or 
more subjects (epimutated subjects) having a beta value 
exceeding three times interquartile ranges (Q1 – 
(3×IQR) and Q3 + (3×IQR)), as reported in [5]. 
 
To calculate Shannon entropy, we applied the 
following procedure, according to [69]: 1) we obtained 
residuals by filtering out the dependence of beta-values 
on blood cells proportions; 2) we recalculated beta-
values according to the formula: 
 
, , ( )
adj
i j i j iresiduals mean b    
 
where mean(i) is the average methylation level for i
th
 
CpG site, i is the index of CpG and j is the index of 
subject. Then, we calculated Shannon entropy using the 
following formula, as indicated in [31]: 
 






Entropy N  
 






 is the recalculated methylation level for i
th
 
CpG site and N is the number of CpG sites. 
 
For both epimutations and Shannon entropy, an 
ANCOVA model was calculated and adjusted for the 
interaction term between age and sex.  
 
Gene-targeted DNA methylation analysis 
 
The EpiTYPER assay (Agena) was used to measure 
DNA methylation of FIGN and PRR4 in whole blood 
from 560 subjects belonging to 4 groups: 419 healthy 
controls of different ages, 49 centenarians, 48 
centenarians’ offspring and 44 persons with Down 
Syndrome. Age range and sex distribution of the 4 
cohorts are reported in Supplementary Table 3. All the 
subjects were recruited following the approval by the 
Ethical Committee of Sant’Orsola-Malpighi University 
Hospital (Bologna, Italy). 
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Genomic DNA was extracted using the QIAamp 96 
DNA Blood Kit (Qiagen) and 500 ng were bisulphite 
converted using EZ-96 DNA Methylation Kit (Zymo 
Research Corporation). Ten ng of bisulphite-converted 
DNA were amplified using the following bisulphite-
specific primers, containing tag sequences for the 
EpiTYPER protocol: FIGN forward 
aggaagagagTTTTTTGAAAAGAGAGAAAGAAGGA
; FIGN reverse cagtaatacgactcactatagggagaaggct 
ATAAACAATCAAACCATCCAATTTCTA; PRR4 
forward aggaagagagTTTGTGTTTTGAGTTGAGTTT 
AGAG; PRR4 reverse cagtaatacgactcactatagggagaa 
ggctCCTAAAAATAAAACTTCTATCATCCA. 
Primers for FIGN and PRR4 amplified 
chr2:164,589,883-164,590,418 and chr12:11, 





Enrichment of genomic regions, imprinted genes and 
sex hormone-related genes was calculated using Fisher 
exact test, as implemented in the fisher.test function in 
the stats R package. The lists of imprinted genomic 
regions [33] and of sex hormone-related genes used as 
background are reported in Supplementary File 8. 
Enrichment of GO annotations was calculated using 
the methylgometh function implemented in the 
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Supplementary Figure 1. Enrichment (odds ratio) of genomic localizations for saDMPs (A) and snaDMPs (B). 
  
 





Supplementary Figure 2. Validation of FIGN locus by EpiTYPER. For each of the CpG units returned by the EpiTYPER assay, DNA 
methylation in controls (general population), centenarians, centenarian's offspring and persons with Down syndrome is reported vs the age 
of the subjects. Males are in blue, females are in red. Linear regression between DNA methylation and age was calculated separately for 
males and females in control subjects and was reported in each plot. 
  
 




Supplementary Figure 3. Validation of PRR4 locus by EpiTYPER. For each of the 5 CpG units returned by the EpiTYPER assay, DNA 
methylation in controls (general population), centenarians, centenarian's offspring and persons with Down syndrome is reported vs the age 
of the subjects. Males are in blue, females are in red. Linear regression between DNA methylation and age was calculated separately for 
males and females in control subjects and was reported in each plot. 
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Supplementary Figure 4. Boxplots of DNA methylation for each CpG unit in FIGN amplicon in centenarians, centenarians' 
offspring and Down syndrome cohorts. Left panels: for each CpG unit in FIGN locus, boxplots of DNA methylation in male and female 
centenarians, compared to male and female controls (>80, < 100 years). Middle panels: for each CpG unit in FIGN locus, boxplots of DNA 
methylation in male and females centenarians' offspring, compared to age-matched male and female controls (>54, < 90 years). Right panels: 
for each CpG unit in FIGN locus, boxplots of DNA methylation in male and female Down syndrome persons, compared to age-matched male 
and female controls (>18, < 67 years). 
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Supplementary Figure 5. Boxplots of DNA methylation for each CpG unit in PRR4 amplicon in centenarians, centenarians' 
offspring and Down syndrome cohorts. Left panels: for each CpG unit in PRR4 locus, boxplots of DNA methylation in male and female 
centenarians, compared to male and female controls (>80, < 100 years). Middle panels: for each CpG unit in PRR4 locus, boxplots of DNA 
methylation in male and females centenarians' offspring, compared to age-matched male and female controls (>54, < 90 years). Right panels: 
for each CpG unit in PRR4 locus, boxplots of DNA methylation in male and female Down syndrome persons, compared to age-matched male 
and female controls (>18, < 67 years). 
 
 
www.aging-us.com 24078 AGING 
 
 






Supplementary Figure 7. Histograms of the number of females (red) and males (blue) according to age in GSE40279, 








Supplementary Table 1. Age-by-sex interaction in the number of epimutations and in the values of Shannon entropy. 
ANCOVA p-values are reported for age, sex and age-by-sex interaction effects. 
 Epimutations Entropy 
age sex age:sex age sex age:sex 
GSE40279 6.8093E-08 4.8010E-01 5.1342E-01 7.7160E-01 7.7393E-02 3.6785E-01 
GSE87571 9.1517E-20 9.4685E-01 7.2585E-01 1.4711E-17 1.3101E-01 4.7210E-01 
EPIC 1.6369E-08 5.8827E-02 8.0821E-02 1.3407E-04 4.8294E-05 1.0310E-04 





Supplementary Table 2. Characteristics of the Infinium450k datasets investigated in the present study. 
 GSE40279 GSE87571 EPIC GSE55763 
Number of subjects 656 729 1803 2670 
Number of females 338 388 1114 860 
Number of males 318 341 689 1810 
Age range 19–101 14–94 34–74 35–75 
Ethnic group (Country) 
European and 
Hispanic (USA) 
European (Sweden) European (Italy) 




Supplementary Table 3. Characteristics of the samples analyzed by the EpiTYPER assay. 




Centenarians’ offspring  
n=48 
Down syndrome  
n=44 
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